Related content

Efficacy and Tolerability of Eletriptan vs. Sumatriptan 100 mg for the Acute Treatment of Migraine

By Hettiarachchi J.   Rasmussen S.   Sikes C.   Sun W.  

Headache Care, Vol. 1, Iss. 1, 2004-03 ,pp. : 43-45

Informa Healthcare

Access to resources Recommend Favorite

Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study

By Tfelt-Hansen P.   Bach F.   Daugaard D.   Tsiropoulos I.   Riddersholm B.  

The Journal of Headache and Pain, Vol. 7, Iss. 6, 2006-12 ,pp. : 389-394

Springer Publishing Company

Access to resources Recommend Favorite

A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine

By Dahlöf Carl   Jones Martin   Davis Kim   Loftus Jane   Salonen Reijo  

The Journal of Headache and Pain, Vol. 5, Iss. 2, 2004-08 ,pp. : 115-122

Springer Publishing Company

Access to resources Recommend Favorite

An evolution in switching therapy for psoriasis patients who fail to meet treatment goals

By  

DERMATOLOGIC THERAPY, Vol. 28, Iss. 6, 2015-11 ,pp. : 390-403

John Wiley & Sons Inc

Access to resources Recommend Favorite

Identifying Patients Who Require a Change in Their Current Acute Migraine Treatment: The Migraine Assessment of Current Therapy (Migraine-ACT) Questionnaire

By Dowson A. J.   Tepper S. J.   Baos V.   Baudet F.   D'Amico D.   Kilminster S.  

Headache Care, Vol. 2, Iss. 1, 2004-03 ,pp. : 5-10

Informa Healthcare

Access to resources Recommend Favorite